Sentences with phrase «stage life science companies»

The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that provides an international venue for early stage life science companies across Biotech, Medtech, Diagnostics and Healthcare IT and to source investors from around the globe, create relationships, and eventually, secure funding.

Early Stage Investors and Strategic Partners Matched with Fundraising CEOs and Scientist - Entrepreneurs The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that provides an international venue for early stage life science companies across Biotech, Medtech, Diagnostics and Healthcare IT and to source investors from around the globe, create relationships, and eventually, secure funding.

McDermott created the innovative Life Sciences Entrepreneurs Acceleration Program (LEAP) in 2013 to help emerging and early - stage life sciences companies grow by offering affordable access to strategic legal advice on the full range of transactional, intellectual property, and employment matters..

Not exact matches

5AM Ventures is an early - stage venture capital firm focused on building next - generation life science companies.

Founded in 1981, Zero Stage Capital is a venture capital firm that invests in emerging growth companies in the following technology sectors: information technology, communications, life sciences, and energy technology.

About AVAC Ltd AVAC Ltd. is an Alberta - based investment company investing in promising early - stage commercial ventures in value - added agri - business, information and communications technologies, life sciences, and other industrial technology sectors.

Led by OrbiMed Advisors, an investment management firm focused on the healthcare sector, Caduceus Private Investment funds invest primarily in US mid and late stage private life science companies and medical technologies.

The company's mandate is to foster the commercialization of early - stage life science technologies by providing seed capital, business and technology management expertise, and networking opportunities.

For life - science companies, it also provides configurable laboratory space, hundreds of thousands of dollars of shared laboratory equipment, and a unique «Innovation Lab» that even provides access to small equipment and reagents, helping early - stage companies bridge that critical gap between late - stage academic research and early - stage product development.

TCG's investment strategy runs counter to the prevailing trend in life sciences venture capital toward assembling diversified portfolios of later stage, single product - orientated companies across multiple industry sectors, with proximity to value inflection points and the early identification of a Pharma «buyer» as key investment considerations.

Films that might have fit this putative strand included the charming but overlong Timeless Stories, co-written and directed by Vasilis Raisis (and winner of the Michael Cacoyannis Award for Best Greek Film), a story that follows a couple (played by different actors at different stages of the characters» lives) across the temporal loop of their will - they, won't - they relationship from childhood to middle age and back again — essentially Julio Medem - lite, or Looper rewritten by Richard Curtis; Michalis Giagkounidis's 4 Days, where the young antiheroine watches reruns of Friends, works in an underpatronized café, freaks out her hairy stalker by coming on to him, takes photographs and molests invalids as a means of staving off millennial ennui, and causes ripples in the temporal fold, but the film is as dead as she is, so you hardly notice; Bob Byington's Infinity Baby, which may be a «science - fiction comedy» about a company providing foster parents with infants who never grow up, but is essentially the same kind of lame, unambitious, conformist indie comedy that has characterized U.S. independent cinema for way too long — static, meticulously framed shots in pretentious black and white, amoral yet supposedly lovable characters played deadpan by the usual suspects (Kieran Culkin, Nick Offerman, Megan Mullally, Kevin Corrigan), reciting apparently nihilistic but essentially soft - center dialogue, jangly indie music at the end, and a pretty good, if belated, Dick Cheney joke; and Petter Lennstrand's loveably lo - fi Up in the Sky, shown in the Youth Screen section, about a young girl abandoned by overworked parents at a sinister recycling plant, who is reluctantly adopted by a reconstituted family of misfits and marginalized (mostly puppets) who are secretly building a rocket — it's for anyone who has ever loved the Tintin moon adventures, books with resourceful heroines, narratives with oddball gangs, and the legendary episode of Angel where David Boreanaz turned into a Muppet.

For life sciences companies in every stage of development, the emerging business and technology team at Morgan Lewis provides customized legal guidance and international connection to address critical business issues.Our lawyers and technical specialists in North America, Asia, Europe, and the Middle East deliver pragmatic, goal - oriented advice for life sciences companies.

Dr. Jarrell has experience representing all types of companies and institutions at all stages of the life sciences business lifecycle, as well as those who invest in them.

Dr. Jarrell has experience representing companies and institutions at all stages of the life sciences business lifecycle, as well as those who invest in them.

Life Sciences: represents and advises life sciences clients on various corporate matters including negotiating investments, mergers and acquisitions, public offerings and assisting with corporate and business development strategies for early - stage life science and emerging life sciences companLife Sciences: represents and advises life sciences clients on various corporate matters including negotiating investments, mergers and acquisitions, public offerings and assisting with corporate and business development strategies for early - stage life science and emerging life sciences companlife sciences clients on various corporate matters including negotiating investments, mergers and acquisitions, public offerings and assisting with corporate and business development strategies for early - stage life science and emerging life sciences companlife science and emerging life sciences companlife sciences companies.